Fortress Biotech, Inc.
FBIO
$3.86
$0.277.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.73M | -41.16M | -46.00M | -48.51M | -40.69M |
| Total Depreciation and Amortization | 4.43M | 4.46M | 4.46M | 4.53M | 4.77M |
| Total Amortization of Deferred Charges | 1.44M | 1.74M | 2.05M | 2.26M | 2.53M |
| Total Other Non-Cash Items | -50.87M | -23.34M | -33.29M | -40.66M | -42.31M |
| Change in Net Operating Assets | -20.36M | -16.06M | -7.42M | -19.84M | -23.23M |
| Cash from Operations | -80.09M | -74.37M | -80.19M | -102.22M | -98.94M |
| Capital Expenditure | -- | -- | -- | -28.00K | -29.00K |
| Sale of Property, Plant, and Equipment | 1.17M | 1.17M | -- | 0.00 | 6.00M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 6.09M | -- | -- | -- | -- |
| Other Investing Activities | -15.00M | -15.00M | -15.00M | -35.00K | -1.04M |
| Cash from Investing | -7.75M | -13.84M | -15.00M | -63.00K | 4.94M |
| Total Debt Issued | 38.67M | 43.67M | 43.67M | 53.20M | 19.53M |
| Total Debt Repaid | -1.88M | -1.88M | -1.25M | -534.00K | -10.91M |
| Issuance of Common Stock | 10.47M | 12.17M | 22.23M | 30.85M | 23.79M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -265.00K | -150.00K | -- | -400.00K | -400.00K |
| Total Dividends Paid | 0.00 | -2.01M | -4.02M | -6.02M | -8.03M |
| Other Financing Activities | 38.18M | 43.11M | 10.01M | 11.37M | 59.08M |
| Cash from Financing | 85.18M | 94.92M | 70.64M | 88.45M | 83.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.66M | 6.72M | -24.55M | -13.83M | -10.95M |